Lacy et al. (2020) proposed a classification system of DLBCL including SOCS1/SGK1, which is a group of DLBCL patients with mutations similar to PMBC, and the possibility of misdiagnosing PMBCL as DLBCL had been excluded through pathological review. This evidence concerns the gene SGK1 and diffuse large B-cell lymphoma.